Targeting of fibroblast activation protein with [Tb]Tb-FAP-2286 in treatment-refractory non-small cell lung cancer.
0/5 보강
APA
Dash S, Malasani V, et al. (2026). Targeting of fibroblast activation protein with [Tb]Tb-FAP-2286 in treatment-refractory non-small cell lung cancer.. European journal of nuclear medicine and molecular imaging, 53(3), 1689-1690. https://doi.org/10.1007/s00259-025-07553-z
MLA
Dash S, et al.. "Targeting of fibroblast activation protein with [Tb]Tb-FAP-2286 in treatment-refractory non-small cell lung cancer.." European journal of nuclear medicine and molecular imaging, vol. 53, no. 3, 2026, pp. 1689-1690.
PMID
40974408 ↗
같은 제1저자의 인용 많은 논문 (5)
- Explainable multi-modal deep learning for transparent cancer diagnosis: integrating radiology, clinical features, and decision visualization.
- Targeting MDSCs in cancer: emerging immunotherapeutic and metabolic strategies.
- Human epidermal growth factor receptor-2/neu expression in gallbladder cancer is significantly associated with clinicopathological parameters and survival.
- Correction: Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer.
- Anaesthetic Challenges in a Case of Oral Carcinoma With Anticipated Difficult Airway Posted for Tumour Excision and Reconstruction Surgery.